Long-Acting Recombinant Human Interleukin-7, NT-I7, Increases Cytotoxic CD8+ T Cells and Enhances Survival in Mouse Glioma Models

Researchers assessed regulatory T cells and cytotoxic T lymphocytes in the tumor microenvironment, cervical lymph nodes, spleen, and thymus; and hematopoietic stem and progenitor cells in the bone marrow.